Moleculin Biotech ASCO abstract on Annamycin cardiac safety shows no cardiotoxicity in 90 patients

Moleculin Biotech, Inc.

Abstract accepted for poster at 2026 ASCO Annual Meeting (May 29–June 2, Chicago).
Pooled safety analysis of 90 Annamycin patients; median cumulative dose 660 mg/m2.
No significant LVEF change from baseline (mean diff -0.12%, p=0.84); no dose correlation.
CEO highlights potential to provide anthracycline therapy without cardiotoxicity limits.
Company's Phase 1b/2 AML study previously showed 50% CR and median OS of 12.39 months.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-26-018242
form_type: 8-K
ticker: MBRX
cik: 0001659617
company_name: Moleculin Biotech, Inc.
filed_at: 2026-05-22T20:00:36+00:00
discovered_at: 2026-05-22T20:02:00.472042+00:00
generated_at: 2026-05-22T21:34:51.563555+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-26-018242
json_url: https://secwatch.observer/filing/0001437749-26-018242.json
markdown_url: https://secwatch.observer/filing/0001437749-26-018242.md
text_url: https://secwatch.observer/filing/0001437749-26-018242.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1659617/000143774926018242/0001437749-26-018242-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1659617/000143774926018242/mbrx20260522_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001437749-26-018242

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.